Podcast - Cybersecurity Roundup: Analyzing New and Proposed Rules for Contractors
Cybersecurity Insights: Updates on CMMC Implementation and CUI Identification
Podcast - Third-Party Assessments and NIST SP 800-171
Third-Party Assessments and NIST SP 800-171
[Podcast] AI Risk Management: A Discussion with NIST’s Elham Tabassi on the NIST AI Risk Management Framework
Compliance into the Weeds - ChatGPT for the Compliance Professional
Nota Bene Episode 150: Building an AI Risk Management Framework with Siraj Husain
DoD Cyber: A Conversation with Melissa Vice, COO for DoD’s Vulnerability Disclosure Program
Cybersecurity and Data Privacy Year in Review: Major Breaches, Changes in the Law, and Upcoming Trends
The Government Contracts Cyber Café: Recent Developments Update
How to Respond to President Obama's Cybersecurity Executive Order
Welcome to the November-December edition of Akin Intelligence. As the end of 2024 approached, the European Union (EU) sustained progress on guidance and supporting materials for its AI Act and international AI Safety...more
Welcome to the Akin Intelligence September-October recap. Around the one-year anniversary of the AI Executive Order, the White House announced that agencies had carried out their directives. Members of Congress introduced a...more
Welcome to the June edition of Akin Intelligence. This month, the General Services Administration (GSA) launched its first AI-focused cohort of Presidential Innovation Fellows (PIF), bringing together experts from across the...more
Welcome to the April-May edition of Akin Intelligence. This edition is a double header, covering both months as we prepare for the launch of our new AI Hub—a one-stop resource for AI coverage that will launch soon. Starting...more
This first part of a two-part series on U.S. regulation of artificial intelligence systems provides an overview and modern context for the existing regulatory, legal and risk management landscape for AI systems in the U.S.,...more
On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological...more
Companies are developing, deploying, and interacting with artificial intelligence (AI) technologies more than ever. At Goodwin, we are keeping a close eye on any regulations that may affect companies operating in this...more
The U.S. Food and Drug Administration (FDA) – in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) – recently hosted a one-day virtual public workshop entitled,...more
Artificial Intelligence (“AI”) is driving innovation across industries and is playing an increasing role in everyday life. AI (and, more broadly, algorithms) is being used in diagnostics, enabled medical devices, device...more